#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Emphysema Small intestine neuroendocrine tumour Glomerulonephritis chronic Ocular lymphoma Frontotemporal dementia Systemic lupus erythematosus Anal fistula Soft tissue necrosis Mitochondrial myopathy Prader-Willi syndrome Langerhans' cell histiocytosis Loss of consciousness Non-renal cell carcinoma of kidney Scedosporium infection Proteus syndrome More trials…

    Learn about Rare Diseases

    Loeys-Dietz syndrome – Trials in Disease Prader-Willi syndrome – Treatment Rosai-Dorfman syndrome – Life with Disease Langerhans cell sarcoma – Life with Disease Synovial sarcoma recurrent – Basic Information Glomerulonephritis membranous – Trials in Disease Pulmonary fibrosis – Life with Disease Alport’s syndrome – Diagnostics Sjogren’s syndrome – Diagnostics Metachromatic leukodystrophy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Auto4 Leuprorelin L-Arginine Hydrochloride Oditrasertib Midazolam Arginine Hydrochloride Carboplatin Benzylpenicillin Deferoxamine Apadamtase Alfa Pertuzumab Nadroparin Calcium Treprostinil Sodium Fitusiran Anv600 Human Immunoglobulin G Ecoo75 Paxalisib VOROLANIB Cendakimab More therapies…

    Learn about Your Condition

    Gastrointestinal disorder Lung adenocarcinoma stage III Non-Hodgkin's lymphoma Peritoneal neoplasm Medication overuse headache Spondylolisthesis Petit mal epilepsy Macular oedema Lumbosacral radiculopathy Colitis Glioma Arterial tortuosity syndrome Immune-mediated enterocolitis Asplenia Head and neck cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Inupadenant, Carboplatin, and Pemetrexed for Adults with Metastatic Non-Small Cell Lung Cancer After Immunotherapy

    Not recruiting

    2 1
    Investigated Diseases:
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Inupadenant Hydrochloride
    Belgium Czechia France Germany Italy Spain

  • Study on Pembrolizumab for Patients with Resectable Metastases from Kidney Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Pembrolizumab
    Italy

  • Study of Plozasiran for Adults with Severe Hypertriglyceridemia

    Not recruiting

    3 1
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Belgium Bulgaria Croatia Czechia Hungary Italy +4

  • Study of Buparlisib and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Buparlisib
    • Paclitaxel
    Belgium France Germany Hungary Italy Poland +1

  • Study on the Long-Term Effects of TEV-48574 (Duvakitug) for Adults with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Duvakitug
    Austria Bulgaria Czechia Germany Hungary Italy +4

  • Study on the Effectiveness and Safety of Golcadomide and Rituximab for Patients with Newly Diagnosed Advanced Follicular Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Follicular lymphoma stage II
    • Follicular lymphoma stage III
    • Follicular lymphoma stage IV
    Investigated Drugs:
    • Pegfilgrastim
    • Bendamustine Hydrochloride
    • Betamethasone Sodium Phosphate
    France Germany Italy Poland Spain

  • Study of Berubicin versus Lomustine in adult patients with recurrent Glioblastoma Multiforme after first-line treatment failure

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma multiforme
    Investigated Drugs:
    • Berubicin Hydrochloride
    • Lomustine
    France Italy Spain

  • Study of Elafibranor in Adults with Primary Biliary Cholangitis Who Don’t Respond Well to or Cannot Tolerate Ursodeoxycholic Acid Treatment

    Not recruiting

    3 1
    Investigated Drugs:
    • Elafibranor
    Czechia France Germany Italy Poland Romania +1

  • Study on Fianlimab and Cemiplimab for Adults with Resectable Stage III and IV Melanoma

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Fianlimab
    • Cemiplimab
    Austria France Germany Greece Ireland Italy +2

  • Study on the Safety and Effectiveness of Etrumadenant, Quemliclustat, and Zimberelimab in Patients with Metastatic Colorectal Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Etrumadenant
    • Zimberelimab
    • Calcium Folinate
    France Italy Spain
Previous Page
1 … 44 45 46 47 48 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!